We are live on ! Find out more
HCM

Holland Capital Management Portfolio holdings

AUM $2.28B
1-Year Est. Return 23.08%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+23.08%
3 Year Est. Return
+46.6%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.72B
AUM Growth
+$103M
Cap. Flow
-$104M
Cap. Flow %
-2.21%
Top 10 Hldgs %
35.29%
Holding
71
New
2
Increased
2
Reduced
46
Closed
–

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$42.2M
2
GILD icon
Gilead Sciences
GILD
+$19.9M
3
BKNG icon
Booking.com
BKNG
+$17.1M
4
CTRA
Coterra Energy
CTRA
+$2.63M

Top Sells

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$53.2M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$36.3M
3
MCRS
MICROS SYSTEMS INC
MCRS
+$19.9M
4
RRC icon
Range Resources
RRC
+$3.82M
5
QCOM icon
Qualcomm
QCOM
+$3.65M

Sector Composition

Rank Sector Weight
1 Technology 24.68%
2 Consumer Discretionary 17.03%
3 Healthcare 12.1%
4 Energy 10.59%
5 Communication Services 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PX
26
DELISTED
Praxair Inc
PX
$79.7M 1.69%
600,278
-10,226
-2% -$1.34M
WBC
27
DELISTED
WABCO HOLDINGS INC.
WBC
$78.3M 1.66%
732,972
-13,069
-2% -$1.4M
BMY icon
28
Bristol-Myers Squibb
BMY
$132B
$77.4M 1.64%
1,596,207
-27,664
-2% -$1.36M
OXY icon
29
Occidental Petroleum
OXY
$55.9B
$73M 1.55%
742,668
-21,763
-3% -$2.05M
MNST icon
30
Monster Beverage
MNST
$88.5B
$72.9M 1.54%
6,160,878
-116,538
-2% -$1.33M
VRTX icon
31
Vertex Pharmaceuticals
VRTX
$126B
$72.9M 1.54%
770,187
-518,176
-40% -$36.3M
CERN
32
DELISTED
Cerner Corp
CERN
$71.5M 1.51%
1,386,647
-25,327
-2% -$1.33M
NKE icon
33
Nike
NKE
$61.9B
$71.3M 1.51%
1,837,898
-36,928
-2% -$1.37M
GNC
34
DELISTED
GNC Holdings, Inc.
GNC
$65.6M 1.39%
1,924,913
-35,414
-2% -$1.41M
BLK icon
35
Blackrock
BLK
$176B
$65.5M 1.39%
204,876
-4,071
-2% -$1.25M
INTU icon
36
Intuit
INTU
$89B
$63.6M 1.35%
789,449
-14,140
-2% -$1.09M
CPA icon
37
Copa Holdings
CPA
$5.8B
$55.8M 1.18%
391,188
-6,575
-2% -$921K
RTX icon
38
RTX Corp
RTX
$301B
$54.9M 1.16%
755,628
-14,792
-2% -$1.09M
MCRS
39
DELISTED
MICROS SYSTEMS INC
MCRS
$51.2M 1.08%
753,861
-364,038
-33% -$19.9M
PG icon
40
Procter & Gamble
PG
$339B
$51M 1.08%
648,765
-12,917
-2% -$1.04M
PEP icon
41
PepsiCo
PEP
$190B
$49.8M 1.05%
557,355
-11,417
-2% -$986K
ECL icon
42
Ecolab
ECL
$79.9B
$48.1M 1.02%
431,731
-8,732
-2% -$936K
AMTD
43
DELISTED
TD Ameritrade Holding Corp
AMTD
$46.5M 0.98%
1,484,028
-28,457
-2% -$882K
BMRN icon
44
BioMarin Pharmaceuticals
BMRN
$12.4B
$46.2M 0.98%
742,210
-880,514
-54% -$53.2M
GHL
45
DELISTED
Greenhill & Co., Inc.
GHL
$45.5M 0.96%
923,007
-16,592
-2% -$819K
MSFT icon
46
Microsoft
MSFT
$3.71T
$44.3M 0.94%
1,062,993
-17,185
-2% -$696K
BA icon
47
Boeing
BA
$185B
$41.2M 0.87%
+323,490
New +$42.2M
ADP icon
48
Automatic Data Processing
ADP
$108B
$37.4M 0.79%
537,283
-9,011
-2% -$615K
PRAA icon
49
PRA Group
PRAA
$755M
$8.3M 0.18%
139,350
– –
TIF
50
DELISTED
Tiffany & Co.
TIF
$8.13M 0.17%
81,150
– –
1
2
3

Similar funds

TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return
RBC
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
CAM
Capstone Asset Management Houston, Texas $3.6B AUM 68.52% 1-Year Est. Return
1GA
1st Global Advisors Dallas, Texas $869M AUM 120.54% 1-Year Est. Return

Holland Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Holland Capital Management held 71 positions worth $4.72B, up 2.2% from $4.62B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q2 2014: portfolio turnover was 2.8%. Holland Capital Management opened 2 new positions and made no exits, leaving the 71-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Holland Capital Management's largest Q2 2014 buy was Boeing: 323,490 shares worth $41.2M.
  • Holland Capital Management added most to Gilead Sciences in Q2 2014, an estimated $19.9M increase.
  • Holland Capital Management's biggest Q2 2014 reduction was BioMarin Pharmaceuticals, cutting an estimated $53.2M.
  • Holland Capital Management's ten largest holdings make up 35% of its $4.72B portfolio in Q2 2014.
  • Holland Capital Management opened 2 new positions and closed 0 in Q2 2014.
  • Holland Capital Management's portfolio value rose 2.2% quarter-over-quarter to $4.72B.

Based on Holland Capital Management's 13F filing for Q2 2014, filed 25 Jul 2014.